Danish drug exports set new record

26 March 2006

Figures released by Danish Statistics, the government statistical agency, show that 2005 was a record year for the Danish drug industry, with more than 4.9 billion euros ($5.8 billion) of goods exported, an increase of 13% on the previous year. The main products sold abroad were reme-dies against depression, diabetes and skin disorders.

Commenting on the results, Jan Hylleberg from the Danish Association of the Pharmaceutical Industry (Lif) said that Danish drugmakers had concentrated their R&D on dis-eases that were affecting increasing numbers of people and thinking globally.

Good at innovation

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight